https://www.lifestyleblog.it/blog/2021/04/license-and-commercialization-agreement-between-pierre-fabre-and-valenzabio-on-an-anti-igf-1r-antibody-for-the-development-of-a-novel-treatment-in-thyroid-eye-disease-ted/
License and Commercialization agreement between Pierre Fabre and ValenzaBio on an anti-IGF-1R antibody for the development of a novel treatment in Thyroid Eye Disease (TED)